NCT04606017View on ClinicalTrials.gov

Effect of Vitamin D Supplementation on Infliximab Response in Patients With Crohn's Disease

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

December 31, 2019

Study Completion Date

June 1, 2020

Conditions
Crohn DiseaseVitamin D DeficiencyVitamin D Supplement
Interventions
DRUG

Caltrate Pill

VitD3 supplementation was defined as patients additionally took oral vitD3 (125 IU/d) within 3 days after the first infusion and persisted in the whole follow-up period.

Trial Locations (1)

325000

SAHWenzhouMU, Wenzhou

All Listed Sponsors
lead

Second Affiliated Hospital of Wenzhou Medical University

OTHER

NCT04606017 - Effect of Vitamin D Supplementation on Infliximab Response in Patients With Crohn's Disease | Biotech Hunter | Biotech Hunter